Skip to content

Newsroom

The latest, from us. Publications, press releases, and more.

—Clinical
Light Modulation® LLLT technology has recently been studied in a piece of research in combination therapy with OPE® IPL tech.   The retrospective, monocentric study carried out in the Ophthalmology Department at Brest University Hospital, evaluates the efficacy and tolerance of intense pulsed light (IPL) therapy with low‐level light therapy (LLLT), our patented photo-biomodulation technology, in the treatment of meibomian gland dysfunction (MGD).
We’re proud to announce our Light Modulation® LLLT technology has recently been studied in a piece of research in combination therapy with OPE® IPL tech. The randomized, controlled, blinded study evaluates the efficacy of intense pulsed light (IPL) therapy with low‐level light therapy (LLLT) in the treatment of meibomian gland dysfunction (MGD) and evaporative dry eye (EDE) compared to a control group.
 
—Our Resonance

Our scientific discoveries and our entrepreneurial successes have been featured in the best outlets worldwide.

Get Started Now
Get in touch to find out how you can benefit from the Espansione Ecosystem of Technologies and Solutions.

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
I'd like to receive information about Espansione Group and its products

Thank you for contacting us.